Depression and neurological disorders

被引:29
作者
Benedetti, F
Bernasconi, A
Pontiggia, A
机构
[1] Inst Sci, Dept Neuropsychiat Sci, Milan, Italy
[2] Univ Vita Salute San Raffaele, Ctr Excellence High Field Magnet Resonance Imagin, Milan, Italy
基金
美国国家卫生研究院;
关键词
brain imaging; depression; neurological disorder;
D O I
10.1097/01.yco.0000194147.88647.7f
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of review Clinical studies support a bidirectional link between depression and neurological diseases. Here we review the most recent findings supporting the hypothesis that major depression is a medical illness of the brain which can be elicited by neurological illnesses. Recent findings In the last year major improvements in brain-imaging techniques allowed correlations to be demonstrated between functional and structural brain abnormalities in specific brain areas (prefrontal cortex, hippocampus, cingulate gyrus) and the presence and severity of affective disorders, thus suggesting a neural basis for their onset and progression. Similar lesions, caused by neurological diseases, have been found to correlate with the presence of depression in neurological illnesses, but literature on the topic is still lacking. Depression in neurological disorders responds to the same treatments available for idiopathic major depression, but patients seem to have different sensitivities to side effects depending on their specific neurological syndrome. Most available data come from case reports and open trials. Summary 'Psychiatric' and 'neurologic' depression seem to share common abnormalities in specific brain areas, but sound brain-imaging studies of the neural correlates of depression in neurological disorders are still lacking. Available treatments are efficacious, but no clear-cut guidelines about the best drugs and dosages can be defined because double-blind placebo-controlled studies are still scarce.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 53 条
[1]  
Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
[2]   Fluvoxamine treatment of major depression associated with multiple sclerosis [J].
Benedetti, F ;
Campori, E ;
Colombo, C ;
Smeraldi, E .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 16 (03) :364-366
[3]   Antidepressant and double antidepressant treatment for the affective disorder of epilepsy [J].
Blumer, D .
JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (01) :3-11
[4]  
BROWNING WN, 1990, AM J PSYCHIAT, V147, P1089
[5]   Does serotonin have trophic effects in temporal lobe epilepsy? [J].
Chugani, DC ;
Chugani, HT .
NEUROLOGY, 2003, 60 (05) :736-737
[6]   The neural basis of mood-congruent processing biases in depression [J].
Elliott, R ;
Rubinsztein, JS ;
Sahakian, BJ ;
Dolan, RJ .
ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (07) :597-604
[7]   PATHOLOGICAL CORRELATES OF INCIDENTAL MRI WHITE-MATTER SIGNAL HYPERINTENSITIES [J].
FAZEKAS, F ;
KLEINERT, R ;
OFFENBACHER, H ;
SCHMIDT, R ;
KLEINERT, G ;
PAYER, F ;
RADNER, H ;
LECHNER, H .
NEUROLOGY, 1993, 43 (09) :1683-1689
[8]   Structural brain abnormalities in multiple sclerosis patients with major depression [J].
Feinstein, A ;
Roy, P ;
Lobaugh, N ;
Feinstein, K ;
O'Connor, P ;
Black, S .
NEUROLOGY, 2004, 62 (04) :586-590
[9]   A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil [J].
Finkel, SI ;
Mintzer, JE ;
Dysken, M ;
Krishnan, KRR ;
Burt, T ;
McRae, T .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (01) :9-18
[10]   A PROSPECTIVE-STUDY OF DEPRESSION AND IMMUNE DYSREGULATION IN MULTIPLE-SCLEROSIS [J].
FOLEY, FW ;
TRAUGOTT, U ;
LAROCCA, NG ;
SMITH, CR ;
PERLMAN, KR ;
CARUSO, LS ;
SCHEINBERG, LC .
ARCHIVES OF NEUROLOGY, 1992, 49 (03) :238-244